I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Supplemental Methods from Phase II Study of the Liposomal F..:
Makoto Nishio
;
Shuji Murakami
;
Hisato Kawakami
...
doi:10.1158/2767-9764.25103050.v1. , 2024
Link:
https://doi.org/10.1158/2767-9764.25103050.v1
RT Journal T1
Supplemental Methods from Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort
UL https://suche.suub.uni-bremen.de/peid=base-ftunivoxfordfig:oai:figshare.com:article_25103050&Exemplar=1&LAN=DE A1 Makoto Nishio A1 Shuji Murakami A1 Hisato Kawakami A1 Kyoichi Okishio A1 Motohiro Tamiya A1 Haruki Kobayashi A1 Daichi Fujimoto A1 Shunichi Sugawara A1 Toshiyuki Kozuki A1 Yuko Oya A1 Hiroki Izumi A1 Takayuki Shiroyama A1 Miyako Satouchi A1 Noboru Yamamoto A1 Shota Kaname A1 Daiko Matsuoka A1 Yohei Otake A1 Takao Takase A1 Taro Semba A1 Koichi Azuma YR 2024 K1 Cancer K1 Immuno-oncology K1 Clinical Research and Trials K1 Lung Cancer K1 Clinical Trial Results K1 Phase II clinical trials K1 Immunotherapy K1 Checkpoint blockade K1 Combination immunotherapy JF doi:10.1158/2767-9764.25103050.v1 LK http://dx.doi.org/https://doi.org/10.1158/2767-9764.25103050.v1 DO https://doi.org/10.1158/2767-9764.25103050.v1 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)